Zacks Sell List Highlights: True Religion Apparel, Crucell N.V. (ADR), Liz Claiborne, Inc. and Quest Diagnostics Inc - Press Releases

For Immediate Release

 

Chicago, IL – November 18, 2010 – Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List – Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong Sell): True Religion Apparel, Inc. (TRLG) and Crucell N.V. (ADR) (CRXL).Further, Zacks announced #4 Rankings (Sell) on two other widely held stocks: Liz Claiborne, Inc. (LIZ)and Quest Diagnostics Inc. (DGX).To see the full Zacks #5 Rank List - Stocks to Sell Now visit: http://at.zacks.com/?id=92

 

Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List of Stocks to Sell Now by 80% annually (+2% vs. +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid.    

Here is a synopsis of why TRLG and CRXL have a Zacks Rank of #5 (Strong Sell) and should most likely be sold or avoided for the next one to three months. Note that a #5 Strong Sell rating is applied to 5% of all the stocks in the Zacks Rank universe:

True Religion Apparel, Inc.  (TRLG ) reported third quarter earnings of 48 cents per share on November 3, which came in 10 cents behind analyst's expectations. The Zacks Consensus Estimate for the current year decreased 22 cents to $1.85 over the past month as all the 5 covering analysts cut back on projections. During that period next year's forecast fell 31 cents to $2.10 per share.

 

Crucell N.V. (ADR) (CRXL)announced third - quarter loss per share of 43 cents on November 9, which fell short of the Zacks Consensus Estimate by 61%. The Zacks Consensus Estimate for 2010 slipped 32 cents to a loss of 47 cents per share in the last week, which reflected reductions by all the 4 covering analysts. Next year's estimate fell 8 cents to 69 cents per share in the same period.

 

Here is a synopsis of why LIZ and DGX have a Zacks Rank of 4 (Sell) and should also most likely be sold or avoided for the next one to three months. Note that a #4 Sell rating is applied to 15% of all the stocks ranked by Zacks;

Liz Claiborne, Inc.(LIZ) On November 4 Liz Claiborne, Inc. reported a loss of 24 cents per share, which lagged the Zacks Consensus Estimate by nearly 22%. The Zacks Consensus Estimate for the present year fell 20 cents to a loss of 66 cents per share in the past 30 days as 6 out of the 7 covering analysts reduced forecasts. 

 

Quest Diagnostics Inc.'s (DGX) first-quarter earnings of 41 cents per share, reported on October 28, missed analysts' projections by nearly 13%. The Zacks Consensus Estimate for 2010 slid 12 cents to $1.90 per share in the last 30 days as all the 14 covering analysts revised downward. The average forecast for the following year declined 14 cents to $2.18 per share in that time span.

 

Truly taking advantage of the Zacks Rank requires the understanding of how it works. The free special report; “Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions” is available to provide this insightful background. Download a free copy now to prosper in the years to come at http://at.zacks.com/?id=93

 

About the Zacks Rank

 

Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." Since inception in 1988, #1 Rank Stocks have generated an average annual return of +27%. During the 2000-2002 bear market, Zacks #1 Rank stocks gained +43.8%, while the S&P 500 tumbled -37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have significantly underperformed the S&P 500 (-0.9% versus +9%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively.

 

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

 

Zacks “Profit from the Pros” e-mail newsletter offers continuous coverage of Zacks Rank Buy stocks and highlights those stocks poised to outperform the market. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=94

 

About Zacks

 

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=95

 

Follow us on Twitter: http://twitter.com/zacksresearch

 

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts  

 

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

 

Contact: Michael Vodicka
Company: Zacks.com
Phone: 312-265-9226
Email: pr@zacks.com

Visit: www.Zacks.com

 
CRUCELL-ADR (CRXL): Free Stock Analysis Report
 
QUEST DIAGNOSTC (DGX): Free Stock Analysis Report
 
LIZ CLAIBORNE (LIZ): Free Stock Analysis Report
 
TRUE RELIGION (TRLG): Free Stock Analysis Report
 
Zacks Investment Research